Abbott Shares Drop on Weak Nutrition Unit, Q1 Guidance Miss
Abbott Laboratories fell after disappointing Q4 results and guidance, driven by challenges in its nutrition business segment. Abbott Laboratories (NYSE:ABT) closed at $87.77 on May 22, 2026, reflecting a 5.81% decline over the past month and a 33.43% drop over the last 52